Abstract
We investigated the in vitro and in vivo osteogenic activity of licochalcone A. At low concentrations, licochalcone A stimulated the differentiation of mouse pre-osteoblastic MC3T3-E1 subclone 4 (MC4) cells and enhanced the bone morphogenetic protein (BMP)-2-induced stimulation of mouse bi-potential mesenchymal precursor C2C12 cells to commit to the osteoblast differentiation pathway. This osteogenic activity of licochalcone A was accompanied by the activation of extracellular-signal regulated kinase (ERK). The involvement of ERK was confirmed in a pharmacologic inhibition study. Additionally, noggin (a BMP antagonist) inhibited the osteogenic activity of licochalcone A in C2C12 cells. Licochalcone A also enhanced the BMP-2-stimulated expression of various BMP mRNAs. This suggested that the osteogenic action of licochalcone A in C2C12 cells could be dependent on BMP signaling and/or expression. We then tested the in vivo osteogenic activity of licochalcone A in two independent animal models. Licochalcone A accelerated the rate of skeletal development in zebrafish and enhanced woven bone formation over the periosteum of mouse calvarial bones. In summary, licochalcone A induced osteoblast differentiation with ERK activation in both MC4 and C2C12 cells and it exhibited in vivo osteogenic activity in zebrafish skeletal development and mouse calvarial bone formation. The dual action of licochalcone A in stimulating bone formation and inhibiting bone resorption, as described in a previous study, might be beneficial in treating bone-related disorders.
Similar content being viewed by others
References
Bessa PC, Cerqueira MT, Rada T, Gomes ME, Neves NM, Nobre A, Reis RL, Casal M (2009) Expression, purification and osteogenic bioactivity of recombinant human BMP-4, -9, -10, -11 and -14. Protein Expr Purif 63(2):89–94
Boden SD, Zdeblick TA, Sandhu HS, Heim SE (2000) The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25(3):376–381
Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423(6937):337–342
Candeliere GA, Liu F, Aubin JE (2001) Individual osteoblasts in the developing calvaria express different gene repertoires. Bone 28(4):351–361
Chae HJ, Jeong BJ, Ha MS, Lee JK, Byun JO, Jung WY, Yun YG, Lee DG, Oh SH, Chae SW, Kwak YG, Kim HH, Lee ZH, Kim HR (2002) ERK MAP kinase is required in 1, 25(OH)2D3-induced differentiation in human osteoblasts. Immunopharmacol Immunotoxicol 24(1):31–41
Chen D, Harris MA, Rossini G, Dunstan CR, Dallas SL, Feng JQ, Mundy GR, Harris SE (1997) Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 60(3):283–290
Du SJ, Frenkel V, Kindschi G, Zohar Y (2001) Visualizing normal and defective bone development in zebrafish embryos using the fluorescent chromophore calcein. Dev Biol 238(2):239–246
Eferl R, Hoebertz A, Schilling AF, Rath M, Karreth F, Kenner L, Amling M, Wagner EF (2004) The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO 23(14):2789–2799
Fleming A, Sato M, Goldsmith P (2005) High-throughput in vivo screening for bone anabolic compounds with zebrafish. J Biomol Screen 10(8):823–831
Fu Y, Hsieh TC, Guo J, Kunicki J, Lee MY, Darzynkiewicz Z, Wu JM (2004) Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun 322(1):263–270
Fu B, Li H, Wang X, Lee FS, Cui S (2005) Isolation and identification of flavonoids in licorice and a study of their inhibitory effects on tyrosinase. J Agric Food Chem 53(19):7408–7414
Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S (2001) Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28(5):491–498
Garces C, Garcia LE (2006) Combination of anabolic and antiresorptive agents for the treatment of osteoporosis. Maturitas 54(1):47–54
Gersbach CA, Byers BA, Pavlath GK, Garcia AJ (2004) Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp Cell Res 300(2):406–417
Ha H, Lee JH, Kim HN, Kim HM, Kwak HB, Lee S, Kim HH, Lee ZH (2006) α-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis. J Immunol 176(1):111–117
Harada S, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature 423(6937):349–355
Hipskind RA, Bilbe G (1998) MAP kinase signaling cascades and gene expression in osteoblasts. Front Biosci 3:d804–d816
Jochum W, David JP, Elliott C, Wutz A, Plenk H Jr, Matsuo K, Wagner EF (2000) Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6(9):980–984
Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127(6 Pt 1):1755–1766
Kawai M, Bessho K, Maruyama H, Miyazaki J, Yamamoto T (2006) Simultaneous gene transfer of bone morphogenetic protein (BMP)-2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression. BMC Musculoskelet Disord 7:62
Kim HJ, Kim SH (2010) Tanshinone IIA enhances BMP-2-stimulated commitment of C2C12 cells into osteoblasts via p38 activation. Amino Acids 39(5):1217–1226
Kim SN, Kim MH, Min YK, Kim SH (2008a) Licochalcone A inhibits the formation and bone resorptive activity of osteoclasts. Cell Biol Int 32(9):1064–1072
Kim MH, Ryu SY, Bae MA, Choi JS, Min YK, Kim SH (2008b) Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis. Food Chem Toxicol 46(11):3375–3382
Kim JM, Lee SU, Kim YS, Min YK, Kim SH (2008c) Baicalein stimulates osteoblast differentiation via coordinating activation of MAP kinases and transcription factors. J Cell Biochem 104(5):1906–1917
Kolbe L, Immeyer J, Batzer J, Wensorra U, Dieck KT, Mundt C, Wolber R, Stab F, Schonrock U, Ceilley RI, Wenck H (2006) Anti-inflammatory efficacy of licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res 298(1):23–30
Lee SU, Kang NS, Min YK, Kim SH (2010) Camphoric acid stimulates osteoblast differentiation and induces glutamate receptor expression. Amino Acids 38(1):85–93
Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA (2003) Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 10(20):1735–1743
Lian JB, Stein JL, Stein GS, van Wijnen AJ, Montecino M, Javed A, Gutierrez S, Shen J, Zaidi SK, Drissi H (2003) Runx2/Cbfa1 functions: diverse regulation of gene transcription by chromatin remodeling and co-regulatory protein interactions. Connect Tissue Res 44(Suppl 1):141–148
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25(4):402–408
McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS (1996) Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. Endocrinology 137(10):4398–4408
McCauley LK, Koh AJ, Beecher CA, Rosol TJ (1997) Proto-oncogene c-fos is transcriptionally regulated by parathyroid hormone (PTH) and PTH-related protein in a cyclic adenosine monophosphate-dependent manner in osteoblastic cells. Endocrinology 138(12):5427–5433
Mi-Ichi F, Miyadera H, Kobayashi T, Takamiya S, Waki S, Iwata S, Shibata S, Kita K (2005) Parasite mitochondria as a target of chemotherapy: inhibitory effect of licochalcone A on the Plasmodium falciparum respiratory chain. Ann NY Acad Sci 1056:46–54
Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K, Yamamura M, Makino H (2007) TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun 356(4):1004–1010
Narayanan K, Srinivas R, Peterson MC, Ramachandran A, Hao J, Thimmapaya B, Scherer PE, George A (2004) Transcriptional regulation of dentin matrix protein 1 by JunB and p300 during osteoblast differentiation. J Biol Chem 279(43):44294–44302
Phimphilai M, Zhao Z, Boules H, Roca H, Franceschi RT (2006) BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res 21(4):637–646
Putnam SE, Scutt AM, Bicknell K, Priestley CM, Williamson EM (2007) Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res 21(2):99–112
Rafi MM, Rosen RT, Vassil A, Ho CT, Zhang H, Ghai G, Lambert G, DiPaola RS (2000) Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res 20(4):2653–2658
Renault MA, Jalvy S, Potier M, Belloc I, Genot E, Dekker LV, Desgranges C, Gadeau AP (2005) UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J Biol Chem 280(4):2708–2713
Rosen CJ, Bilezikian JP (2001) Clinical review 123: anabolic therapy for osteoporosis. J Clin Endocrinol Metab 86(3):957–964
Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365–386
Sakata R, Minami S, Sowa Y, Yoshida M, Tamaki T (2004) Trichostatin A activates the osteopontin gene promoter through AP1 site. Biochem Biophys Res Commun 315(4):959–963
Shibata S (2000) A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120(10):849–862
Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K (2002) Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J Biol Chem 277(39):36024–36031
Suzuki A, Guicheux J, Palmer G, Miura Y, Oiso Y, Bonjour JP, Caverzasio J (2002) Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 30(1):91–98
Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE (2002) Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 395:110–120
Wagner EF (2002) Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 61(Suppl 2):ii40–ii42
Whelan AM, Jurgens TM, Bowles SK (2006) Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials. Ann Pharmacother 40(5):836–849
Wu CC, Li YS, Haga JH, Wang N, Lian IY, Su FC, Usami S, Chien S (2006) Roles of MAP kinases in the regulation of bone matrix gene expressions in human osteoblasts by oscillatory fluid flow. J Cell Biochem 98(3):632–641
Yeh LC, Tsai AD, Lee JC (2002) Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J Cell Biochem 87(3):292–304
Zayzafoon M, Stell C, Irwin R, McCabe LR (2000) Extracellular glucose influences osteoblast differentiation and c-Jun expression. J Cell Biochem 79(2):301–310
Acknowledgments
CHK was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1020090). This study was supported by a grant from the National R&D program of the Korea Ministry of Education, Science, and Technology, Republic of Korea (Chemical Genomics Research, 20100002073).
Author information
Authors and Affiliations
Corresponding authors
Additional information
S. H. Kim and C. H. Kim are corresponding authors. S. N. Kim and S. J. Bae contributed equally to this study.
Rights and permissions
About this article
Cite this article
Kim, S.N., Bae, S.J., Kwak, H.B. et al. In vitro and in vivo osteogenic activity of licochalcone A. Amino Acids 42, 1455–1465 (2012). https://doi.org/10.1007/s00726-011-0901-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-011-0901-7